Related Experiment Video
Updated: Aug 23, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
p53 targets simian virus 40 large T antigen for acetylation by CBP
Danielle L Poulin1, Andrew L Kung, James A DeCaprio
1Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Simian virus 40 (SV40) large T antigen (T Ag) interacts with the tumor suppressor p53 and the transcriptional coactivators CBP and p300. Binding of these cellular proteins in a ternary complex has been implicated in T Ag-mediated transformation. It has been suggested that the ability of CBP/p300 to modulate p53 function underlies p53's regulation of cell proliferation and tumorigenesis. In this study, we provide further evidence that CBP activity may be mediated through its synergistic action with p53. We demonstrate that SV40 T Ag is acetylated in vivo in a p53-dependent manner and T Ag acetylation is largely mediated by CBP. The acetylation of T Ag is dependent on its interaction with p53 and on p53's interaction with CBP. We have mapped the site of acetylation on T Ag to the C-terminal lysine residue 697. This acetylation site is conserved between the T antigens of the human polyomaviruses JC and BK, which are also known to interact with p53. We show that both JC and BK T antigens are also acetylated at corresponding sites in vivo. While other proteins are known to be acetylated by CBP/p300, none are known to depend on p53 for acetylation. T Ag acetylation may provide a regulatory mechanism for T Ag binding to a cellular factor or play a role in another aspect of T Ag function.
Insights
Simian virus 40 (SV40) large T antigen acetylation depends on p53 and CBP. This acetylation, occurring at lysine 697, is conserved in related human polyomavirus T antigens, suggesting a shared regulatory mechanism.
Area of Science:
- Virology
- Molecular Biology
- Cancer Research
Background:
- Simian virus 40 (SV40) large T antigen (T Ag) interacts with tumor suppressor p53 and coactivators CBP/p300.
- This interaction is crucial for T Ag-mediated cellular transformation.
- CBP/p300's modulation of p53 function is linked to cell proliferation and tumorigenesis regulation.
Purpose of the Study:
- To investigate the role of CBP/p300 in SV40 T Ag function.
- To explore the interplay between p53, CBP, and SV40 T Ag acetylation.
- To identify the specific acetylation site on T Ag and its conservation.
Main Methods:
- In vivo acetylation assays of SV40 T Ag.
- Analysis of T Ag acetylation dependence on p53 and CBP.
- Mapping of the T Ag acetylation site.
- Comparative analysis of T antigens from human polyomaviruses JC and BK.
Main Results:
- SV40 T Ag is acetylated in vivo in a p53-dependent manner, primarily mediated by CBP.
- T Ag acetylation requires the interaction between T Ag and p53, and between p53 and CBP.
- Acetylation occurs at C-terminal lysine residue 697 of T Ag.
- Corresponding acetylation sites were found in JC and BK T antigens.
Conclusions:
- CBP-mediated acetylation of SV40 T Ag is dependent on p53.
- This p53-dependent acetylation mechanism is conserved among human polyomavirus T antigens.
- T Ag acetylation may regulate T Ag binding or other functions.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

